Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Main Capital and Onventis in connection with their acquisition of Spendency AB
Mandate

Vinge advises Main Capital and Onventis in connection with their acquisition of Spendency AB

November 29, 2021 Employment and Benefits Commercial Agreements Intellectual Property IT, Telecommunications and Outsourcing M&A

Established in 2015, with headquarters in Stockholm, Spendency has grown into a leading spend analytics provider.

Connected directly to the clients’ ERP and/or procurement system, Spendency helps its customers to collect, enrich and normalise supplier data. Spendency serves a vast customer base of more than 100 customers and over 1,500 users. Through the acquisition, Onventis strategically expands its product offering within spend analytics.

Vinge’s team consisted of Filip Öhrner and Eléonore Friberg (M&A), Ebba Svenburg (Employment), Karl-Hugo Engdahl (Agreements), Karolina Fuhrman (GDPR/IT), Arvid Axelryd (IP) and Jessica Henning (VDR).

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025